MedTrace Logo

Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population

NCT04310566 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2022-01-19

Study results available
· View outcomes & findings →

Summary

This is a single-masked, crossover, randomized-controlled, dispensing clinical trial. A total of approximately 70 myopic eligible subjects will be targeted to complete the study.

Conditions

  • Visual Acuity

Interventions

DEVICE

JJVC Investigational Multifocal Contact Lens (senofilcon A c3)

TEST

DEVICE

Dailies Total 1® Multifocal Contact Lens

CONTROL

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-21
Primary Completion
2020-03-28
Completion
2020-03-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04310566 on ClinicalTrials.gov